Vanguard Group Inc Bausch Health Companies Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,770,104 shares of BHC stock, worth $84.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,770,104

Previous 11,746,480 0.2%

Holding current value

$84.5 Million

Previous $76 Million 3.14%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$4.32 - $6.66 $102,055 - $157,335	23,624 Added 0.2%	11,770,104 $78.4 Million
Q1 2025 May 09, 2025	BUY	$6.16 - $7.94 $379,585 - $489,270	61,621 Added 0.53%	11,746,480 $76 Million
Q4 2024 Feb 11, 2025	BUY	$7.34 - $9.78 $1.06 Million - $1.42 Million	145,078 Added 1.26%	11,684,859 $94.2 Million
Q3 2024 Nov 13, 2024	BUY	$5.22 - $8.26 $516,090 - $816,649	98,868 Added 0.86%	11,539,781 $94 Million
Q2 2024 Aug 13, 2024	SELL	$6.1 - $10.41 $1.67 Million - $2.84 Million	-273,080 Reduced 2.33%	11,440,913 $79.7 Million
Q1 2024 May 10, 2024	BUY	$7.77 - $10.61 $892,477 - $1.22 Million	114,862 Added 0.99%	11,713,993 $124 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $727,200 - $916,517	111,363 Added 0.97%	11,599,131 $93 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $1.35 Million - $1.7 Million	175,489 Added 1.55%	11,487,768 $94.4 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $1.06 Million - $1.63 Million	185,159 Added 1.66%	11,312,279 $90.5 Million
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $200,721 - $314,825	31,962 Added 0.29%	11,127,120 $90.1 Million
Q4 2022 Feb 10, 2023	BUY	$6.09 - $7.93 $1.04 Million - $1.35 Million	170,783 Added 1.56%	11,095,158 $69.7 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $1 Million - $2.02 Million	219,279 Added 2.05%	10,924,375 $75.3 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $3.39 Million - $11.3 Million	479,538 Added 4.69%	10,705,096 $89.5 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $7.24 Million - $9.31 Million	335,045 Added 3.39%	10,225,558 $234 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $6.38 Million - $8.04 Million	277,188 Added 2.88%	9,890,513 $273 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $7.66 Million - $9.2 Million	306,091 Added 3.29%	9,613,325 $268 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $255 Million - $304 Million	9,307,234 New	9,307,234 $273 Million

Others Institutions Holding BHC

# of Institutions

252

Shares Held

243M

Call Options Held

2.44M

Put Options Held

8.42M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.6B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Bausch Health Companies Inc. Transaction History